Extracorporeal Shock Wave Lithotripsy Market - Top Companies and Manufacturers

  • Report ID: 3932
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Companies Dominating the Extracorporeal Shock Wave Lithotripsy (ESWL) Landscape

top-features-companies
    • Siemens AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Boston Scientific Corporation
    • C.R. Bard Inc.
    • Cook Group Inc.
    • Medtrue Enterprise Co. Ltd.
    • Jiangsu Sainty Handsome Co., Ltd.
    • Lumenis LTD
    • Olympus Corporation
    • Dornier MedTech GmbH
    • Karl Storz Gmbh and Co. KG


In the News

  • Karl Storz Gmbh and Co. KG received clearance from the U.S. Food and Drug Administration (FDA) for MODULITH SLX-F2 extracorporeal shock wave lithotripter. With this device, children over the age of three years suffering from stone disease can now be treated non-invasively.

  • Dornier MedTech GmbH launched UroX, which is a community that connects professionals from various disciplines to cultivate innovative solutions and solve complex challenges in urology.


Author Credits:  Radhika Pawar


  • Report ID: 3932
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of extracorporeal shock wave lithotripsy is estimated at USD 444.49 Million.

The extracorporeal shock wave lithotripsy market size was over USD 422.8 Million in 2023 and is projected to cross USD 869.18 Million by the end of 2036, growing at more than 5.7% CAGR during the forecast period i.e., between 2024-2036. The major factors driving the market growth during the forecast period are the increasing number of incidences of reporting kidney stones in patients, and the growing prevalence of lifestyle-associated conditions and obesity.

North America is anticipated to account for majority industry share of 32% by 2036, attributed to presence of a large number of diabetic and obese patients who are prone to the development of kidney stones and gallstones.

Siemens AG, Boston Scientific Corporation, C.R. Bard Inc., Cook Group Inc., Medtrue Enterprise Co. Ltd., Jiangsu Sainty Handsome Co., Ltd., Lumenis LTD, Olympus Corporation, Dornier MedTech GmbH, Karl Storz Gmbh and Co. KG
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying